Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC - PubMed (original) (raw)

Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC

Jun Ma et al. BMC Complement Altern Med. 2010.

Abstract

Background: Curcumin has anti-inflammatory, anti-oxidant, and anti-proliferative properties, and depending upon the experimental circumstances, may be pro- or anti-apoptotic. Many of these biological actions could ameliorate diabetic nephropathy.

Methods/design: Mouse podocytes, cultured in basal or high glucose conditions, underwent acute exposure to curcumin. Western blots for p38-MAPK, COX-2 and cleaved caspase-3; isoelectric focusing for HSP25 phosphorylation; and DNase I assays for F- to G- actin cleavage were performed for in vitro analyses. In vivo studies examined the effects of dietary curcumin on the development of diabetic nephropathy in streptozotocin (Stz)-induced diabetes in DBA2J mice. Urinary albumin to creatinine ratios were obtained, high performance liquid chromatography was performed for urinary curcuminoid measurements, and Western blots for p38-MAPK and total HSP25 were performed.

Results: Curcumin enhanced the phosphorylation of both p38MAPK and downstream HSP25; inhibited COX-2; induced a trend towards attenuation of F- to G-actin cleavage; and dramatically inhibited the activation of caspase-3 in vitro. In curcumin-treated DBA2J mice with Stz-diabetes, HPLC measurements confirmed the presence of urinary curcuminoid. Nevertheless, dietary provision of curcumin either before or after the induction of diabetes failed to attenuate albuminuria.

Conclusions: Apart from species, strain, early differences in glycemic control, and/or dosing effects, the failure to modulate albuminuria may have been due to a decrement in renal HSP25 or stimulation of the 12/15 lipoxygenase pathway in DBA2J mice fed curcumin. In addition, these studies suggest that timed urine collections may be useful for monitoring curcumin dosing and renal pharmacodynamic effects.

PubMed Disclaimer

Figures

Figure 1

Curcumin activates p38MAPK and phosphorylates HSP25 in cultured Pods. 5.5 mM glucose (NG), 5.5 mM glucose+30 μM curcumin (NG+Cur), 30 mM glucose (HG), 30 mM glucose+30 μM curcumin (HG+Cur), 5.5 mM glucose+24.5 mM mannitol (NG+M). (a) Representative Western blots of phospho-specific p38MAPK (pp38MAPK) and quantitative evaluation of pp38MAPK relative to total p38MAPK (p38MAPK) by densitometric analysis. (b) Representative IEF separating total HSP25 into its nonphosphorylated isoform (P0), mono- (P1), and bi-phoshorylated (P2) isoforms, Western blots of HSP25, and quantitative evaluation of relative phosphorylated HSP25 isoforms to total HSP25 ((P1 + P2)/(P0 + P1 + P2)) by densitometry analysis. Mannitol values (n = 2) are not displayed but were similar to NG. (c) DNAse I assay of F-actin/G-actin ratios. All data expressed as mean ± SEM (n = 3). *P < 0.05 compared with NG; #P < 0.01 compared with NG; **P < 0.05 compared with HG; ##P < 0.01 compared with HG.

Figure 2

Curcumin prevents activation of Caspase 3 and inhibits COX-2 in cultured Pods. Representative Western blot analysis of activated Caspase 3 (a) and COX-2 (b) in Pods. 5.5 mM glucose (NG), 5.5 mM glucose+30 μM curcumin (NG+Cur), 30 mM glucose (HG), 30 mM glucose+30 μM curcumin (HG+Cur). Results were normalized with GAPDH. All data expressed as mean ± SEM (n = 3). *P < 0.05 compared with NG; #P < 0.01 compared with NG; ##P < 0.01 compared with HG.

Figure 3

Fasting blood glucose values and effects of curcumin on DN measured by urinary albumin/creatinine in noDM and DM mice. (a) Fasting blood glucose in mice in Experiments 1 and 2. 24 h urine was collected to measure Ualb/cr in noDM and DM mice. (b) Ualb/cr from urine collected on days 9-15 for noDM and DM mice given control chow (0 ppm curcumin) or chow with 5,000 ppm curcumin. Mice were fed curcumin post-Stz injections (Experiment 1). (c) Ualb/cr at 2, 4 and 7 weeks for noDM and DM mice given control chow (0 ppm) or curcumin chow (data pooled for mice fed 5,000 and 7,500 ppm curcumin). Mice were fed curcumin pre-Stz injections (Experiment 2). All data are log-transformed (log10). *P < 0.05

Figure 4

Urinary curcuminoid excretion in noDM and DM mice fed with curcumin versus control chow. Curcumin metabolites were measured by High Performance Liquid Chromatography (HPLC) as a measure of bioavailability in a timed urine collection. (a) Total urinary curcuminoids in nmol and (b) Urinary curcumin/creatinine in nmol/mg. All data are log-transformed (log10). *P < 0.05; #P < 0.01.

Figure 5

Mouse Food Intake. After Stz-injection and curcumin feeding began (Experiment 1), the total amount of control chow (0 ppm curcumin) or curcumin chow (5,000 ppm curcumin) consumed by each mouse over the preceding 4 days was measured on day 4. *P < 0.05.

Figure 6

Effects of Curcumin on p38MAPK and total HSP25 on Stz-DM mice. Representative Western blot and quantitative evaluation of phospho-specific p38MAPK (a) and total HSP25 relative to GAPDH (b) in renal cortex of DMCur0 and DMCur5,000 mice. *P < 0.05; #P < 0.01.

Figure 7

Curcumin did not lower U 12-HETE/cr excretion in noDM and DM mice. Urinary 12-HETE/cr ratios for noDM and DM mice fed chow with 0 and 5,000 ppm curcumin. Mice were fed curcumin post-Stz injections (Experiment 1). Graph represents pooled data (day 9 and 15). *P < 0.05; #P < 0.01.

References

1. Schieppati A, Remuzzi G. Proteinuria and its consequences in renal disease. Acta Paediatr Suppl. 2003;92(443):9–13. -PubMed
1. Hall A. G proteins and small GTPases: distant relatives keep in touch. Science. 1998;280(5372):2074–5. doi: 10.1126/science.280.5372.2074. -DOI -PubMed
1. Raman N, Atkinson SJ. Rho controls actin cytoskeletal assembly in renal epithelial cells during ATP depletion and recovery. Am J Physiol. 1999;276(6 Pt 1):C1312–24. -PubMed
1. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N. et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 1995;81(7):1137–46. doi: 10.1016/S0092-8674(05)80018-2. -DOI -PubMed
1. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 1995;81(7):1147–57. doi: 10.1016/S0092-8674(05)80019-4. -DOI -PubMed

Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC - PubMed (original) (raw)